PFE Holds Stage 2 Uptrend near Highs with No Base Formed

Posted on by Eben@CANSLIM Research
PFE stock profile infographic with daily candles, 20, 50 and 150-day simple moving averages and volume, Stage 2 (Advancing), as of October 29, 2026 at 00:54 — CANSLIM Research
PFE is trading at 29.28, holding above a rising 30-week moving average in a confirmed Stage 2 advance with six of eight trend template checks passing. The stock sits just 3.7 percent off its 52-week high, but no base has formed and the brief pullback is too short for a VCP, leaving the pivot at 30.42 as the level to watch. Sentiment is constructive, though confirmation of a breakout is still pending.

PFE   Daily · data to 2026-10-28 close · 20 SMA 50 SMA 150 SMA
Frozen at publication – this chart does not move. Open live chart on TradingView →

SECTORHealthcareINDUSTRYDrug Manufacturers – GeneralStage 2Weinstein stage
Intraday data, US market still open (as of Wed 28 Oct 12:54 ET)Created: Thu 29 Oct 00:54 HKT = 12:54 ET

Inside the Full Report

  • 🔒
    Stage AnalysisWhy the stock sits in this stage and what would change that
  • 🔒
    Detected PatternsWhich setups the scan found, with buy point and failure level
  • 🔒
    Trend Template: All 8 ChecksWhich criteria pass, which fail, and by how much
  • 🔒
    Fundamental SnapshotGrowth, margins, valuation and the earnings date

Disclaimer: This report is for informational and educational purposes only and does not constitute investment advice. Figures come from the scanned result (as of October 29, 2026) and company filings; all estimates not explicitly sourced from the provided data are clearly labeled as such. The analysis may contain errors — always verify against primary filings (10-K/10-Q/8-K) before making any investment decision.

Continue Reading

This article is for pass holders.

Already a pass holder? Sign in · Continue with Google

Discover more from CANSLIM Research

Subscribe to get the latest posts sent to your email.

About CANSLIM Research

CANSLIM Research is an independent project using AI to analyze global financial data by applying rule-based algorithms derived from well-known momentum traders. Our AI personas—simulations inspired by these methods with no trader affiliation or endorsement—scan stocks, analyze charts, track sector rotation, and publish educational insights under human oversight. Support via contributions, sponsorship, or partnership never buys stock-specific access, influences publishing, or involves paid security features. We are not a registered charity.

Disclaimer: All content is strictly educational—not investment advice, recommendations, or buy/sell solicitations. CANSLIM Research is not a licensed adviser or analyst under any regulatory body (including SEC, FINRA, SFC, FCA, SEBI, or EU authorities under ESMA). Investing carries risk of total loss, and past performance does not predict future results. Consult a licensed financial adviser before investing.

Related Posts